|
|
|
Volumn 35, Issue 2, 1997, Pages 77-91
|
|
Symptomatic treatment of neurolathyrism with tolperisone HCL (Mydocalm): A randomized double blind and placebo controlled drug trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CENTRAL MUSCLE RELAXANT;
TOLPERISONE;
ACHILLES TENDON;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FALLING;
FATIGUE;
FEMALE;
HUMAN;
INFANTILE SPASM;
LATHYRISM;
MAJOR CLINICAL STUDY;
MALE;
MUSCLE CRAMP;
MUSCLE TONE;
MYALGIA;
ORAL DRUG ADMINISTRATION;
PALLIATIVE THERAPY;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
STARTLE REFLEX;
SYMPTOM;
VERTIGO;
WALKING;
WALKING SPEED;
ADOLESCENT;
ADULT;
AGED;
CHILD;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MUSCLE RELAXANTS, CENTRAL;
NERVOUS SYSTEM DISEASES;
PLANT POISONING;
TOLPERISONE;
TREATMENT OUTCOME;
VITAMIN B COMPLEX;
|
|
EID: 0030871926
PISSN: 00141755
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (17)
|
